Literature DB >> 22707111

Surveillance of small rectal carcinoid tumors in the absence of metastatic disease.

Sara E Murray1, Rebecca S Sippel, Ricardo Lloyd, Herbert Chen.   

Abstract

BACKGROUND: The incidence of rectal carcinoids is rapidly increasing, typically presenting as small (<1.0 cm), localized tumors. Although the evaluation of rectal carcinoids on presentation is well standardized, surveillance after resection has not been well established.
METHODS: A prospective database documented patients with rectal carcinoids at our institution between January 1995 and September 2011. Information collected included patient and tumor characteristics, treatment method, surveillance schedule, recurrence, and survival.
RESULTS: Twenty-eight patients with rectal carcinoid were identified. Ten patients were excluded for tumors >1 cm, known metastases at presentation, <6 months follow-up, or previous resections. The mean age of the remaining patients was 56 ± 3 years, and 61% of the patients were female. All patients were diagnosed at endoscopy, with 50% diagnosed incidentally on screening endoscopy. Treatment methods included endoscopic therapy (n = 13, 72%), transanal excision (n = 3, 17%), and transanal endoscopic microsurgery (n = 1, 5.5%). One patient (5.5%) received no additional invasive therapy after diagnostic endoscopy. The mean tumor diameter was 4.6 ± 0.5 mm. The average length of follow-up was 5.4 ± 0.9 years, with a median number of 2 follow-up endoscopies (range 0-6). Two patients (11%) died within the follow-up period from noncarcinoid causes. Importantly, no surviving patients developed local or distant recurrence with up to 12.3 years of follow-up.
CONCLUSIONS: On the basis of this experience, patients presenting with small (≤1.0 cm), nonmetastatic rectal carcinoids are unlikely to develop local or distant recurrence after resection. Aggressive surveillance with repeat endoscopies or other imaging studies after resection may be unnecessary in this patient population.

Entities:  

Mesh:

Year:  2012        PMID: 22707111      PMCID: PMC3443297          DOI: 10.1245/s10434-012-2442-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  18 in total

1.  Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine.

Authors:  V ERSPAMER; B ASERO
Journal:  Nature       Date:  1952-05-10       Impact factor: 49.962

Review 2.  Carcinoid tumors.

Authors:  Rebecca S Sippel; Herbert Chen
Journal:  Surg Oncol Clin N Am       Date:  2006-07       Impact factor: 3.495

3.  Rectal carcinoids: the most frequent carcinoid tumor.

Authors:  A B Jetmore; J E Ray; J B Gathright; K M McMullen; T C Hicks; A E Timmcke
Journal:  Dis Colon Rectum       Date:  1992-08       Impact factor: 4.585

4.  Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated colon and rectum tumour/carcinoma.

Authors:  John K Ramage; Peter E Goretzki; Riccardo Manfredi; Paul Komminoth; Diego Ferone; Rudolf Hyrdel; Gregory Kaltsas; Fahrettin Kelestimur; Larry Kvols; Jean-Yves Scoazec; M I Sevilla Garcia; Martyn E Caplin
Journal:  Neuroendocrinology       Date:  2007-11-21       Impact factor: 4.914

5.  An analysis of 8305 cases of carcinoid tumors.

Authors:  I M Modlin; A Sandor
Journal:  Cancer       Date:  1997-02-15       Impact factor: 6.860

6.  Carcinoid tumors of the rectum: effect of size, histopathology, and surgical treatment on metastasis free survival.

Authors:  A N Koura; G G Giacco; S A Curley; J M Skibber; B W Feig; L M Ellis
Journal:  Cancer       Date:  1997-04-01       Impact factor: 6.860

7.  Neuroendocrine tumors of the rectum: a 10-year review of management.

Authors:  Jason R Moore; Brian Greenwell; Kaylee Nuckolls; David Schammel; Nicholas Schisler; Christine Schammel; Patrick Culumovic; Brian P McKinley; Steven D Trocha
Journal:  Am Surg       Date:  2011-02       Impact factor: 0.688

Review 8.  Carcinoids of the rectum: an evaluation of 1271 reported cases.

Authors:  J Soga
Journal:  Surg Today       Date:  1997       Impact factor: 2.540

9.  A 35-year retrospective study of carcinoid tumors in Taiwan: differences in distribution with a high probability of associated second primary malignancies.

Authors:  Anna Fen-Yau Li; Chih-Yi Hsu; Alice Li; Ling-Chen Tai; Wen-Yih Liang; Win-Yin Li; Shyh-Haw Tsay; Jeou-Yuan Chen
Journal:  Cancer       Date:  2008-01-15       Impact factor: 6.860

10.  A 5-decade analysis of 13,715 carcinoid tumors.

Authors:  Irvin M Modlin; Kevin D Lye; Mark Kidd
Journal:  Cancer       Date:  2003-02-15       Impact factor: 6.860

View more
  4 in total

1.  Surveillance strategy for rectal neuroendocrine tumors according to recurrence risk stratification.

Authors:  Dong Hyun Kim; Jin Ha Lee; Yoon Jin Cha; Soo Jung Park; Jae Hee Cheon; Tae Il Kim; Hoguen Kim; Won Ho Kim; Sung Pil Hong
Journal:  Dig Dis Sci       Date:  2013-12-10       Impact factor: 3.199

2.  Current issues involving the treatment of small rectal carcinoid tumors.

Authors:  Dae Kyung Sohn
Journal:  J Korean Soc Coloproctol       Date:  2012-08-31

3.  Management of sub-5 mm rectal carcinoids with lymph node metastases.

Authors:  James Wei Tatt Toh; Christopher Henderson; Takako Eva Yabe; Evonne Ong; Pierre Chapuis; Les Bokey
Journal:  Gastroenterol Rep (Oxf)       Date:  2014-10-22

4.  Factors associated with worse outcomes for colorectal neuroendocrine tumors in radical versus local resections.

Authors:  Osayande Osagiede; Elizabeth Habermann; Courtney Day; Emmanuel Gabriel; Amit Merchea; Riccardo Lemini; Iktej S Jabbal; Dorin T Colibaseanu
Journal:  J Gastrointest Oncol       Date:  2020-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.